SNW1 is a prognostic biomarker in prostate cancer

SNW1 is a prognostic biomarker in prostate cancer

Abstract Background SNW1 is a nuclear receptor co-activator involved in splicing and transcription control, including androgen receptor signaling. Overexpression of SNW1 has been linked to adverse prognosis in different cancer types, but studies on the role of SNW1 in prostate cancer are lacking. Me...

Full description

Bibliographic Details
Main Authors: Doris Höflmayer, Carla Willich, Claudia Hube-Magg, Ronald Simon, Dagmar Lang, Emily Neubauer, Frank Jacobsen, Andrea Hinsch, Andreas M. Luebke, Marie Christina Tsourlakis, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Sarah Minner, Franziska Büscheck, Guido Sauter, Thorsten Schlomm, Stefan Steurer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak, Christian Bernreuther
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Diagnostic Pathology
Subjects:
SNW1
Prostate cancer
Prognosis
TMPRSS2:ERG
SKIP1
Online Access:http://link.springer.com/article/10.1186/s13000-019-0810-8

Internet

http://link.springer.com/article/10.1186/s13000-019-0810-8

Similar Items